Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

167

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
A12CC	MAGNE B6	B	Pyridoxine HCl - 5mg, Magnesium lactate dihydrate - 470mg		Tablet, coated	365,525 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
C07AB12	NEBILET	B	Nebivolol HCl - 5mg	5mg	Tablet, scored	694,767 L.L
C10BX06	TRINOMIA	B	Acetylsalicylic acid - 100mg, Atorvastatin - 20mg, Ramipril - 2.5mg		Capsule, hard	1,029,383 L.L
G01AF02	CANESTEN	B	Clotrimazole - 0.1g	0.1g	Tablet	408,528 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
J01XX08	ZYVOX IV	B	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	4,414,523 L.L
L01BB04	LITAK 10	B	Cladribine - 10mg/5ml	10mg/5ml	Injectable solution	39,016,157 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	692,079 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
C10BX06	TRINOMIA	B	Acetylsalicylic acid - 100mg, Atorvastatin - 20mg, Ramipril - 5mg		Capsule, hard	1,236,335 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
L01BB04	MAVENCLAD	B	Cladribine - 10mg	10mg	Tablet	200,244,812 L.L
N06AX27	SPRAVATO	B	Esketamine - 28mg/device	28mg/device	Solution	25,122,440 L.L
S01BA04	PRED FORTE	B	Prednisolone acetate - 10mg/ml	1%	Drops suspension	260,705 L.L
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	291,614 L.L
A10BA02	GLUCOPHAGE XR	B	Metformin HCl - 1000mg	1000mg	Tablet, prolonged release	755,039 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
C09DA06	BLOPRESS PLUS 8MG	B	Candesartan cilexetil - 8mg, Hydrochlorothiazide - 12.5mg		Tablet	1,060,292 L.L
C10BX06	TRINOMIA	B	Acetylsalicylic acid - 100mg, Atorvastatin - 20mg, Ramipril - 10mg		Capsule, hard	1,596,485 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
M01AX	DORIXINA	B	Lysine clonixinate - 125mg	125mg	Tablet	326,554 L.L
N05AF05	CLOPIXOL DEPOT	B	Zuclopenthixol decanoate - 200mg/ml	200mg/ml	Injectable solution	512,004 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	66,978,978 L.L
S01BA04	PRED FORTE	B	Prednisolone acetate - 10mg/ml	1%	Drops suspension	260,705 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/ml	0.01g/ml	Solution	368,213 L.L

...

167

...